Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	7 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2024
Cash flows from operating activities:
Net loss	$ (2,828,585)	$ (14,185,887)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock based compensation		7,034,079
Change in fair value of investment in equity securities		150,994
Change in fair value of SAFE notes		955,000
Change in fair value of warrant liability		2,753,964
Change in fair value of convertible notes		471,400
Change in fair value of earnout shares		(1,636,100)
Depreciation expense		1,074
SAFE notes issuance costs	466,302
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(15,000)	(461,575)
Accounts payable	733,998	(4,055,728)
Accrued liabilities and other current liabilities	11,240	458,618
Due to related parties	49,616
Net cash used in operating activities	(1,582,429)	(8,514,161)
Cash flows from investing activities:
Pre-acquisition capital project costs	(25,000)	(726,102)
Investment in other long-term assets		(50,000)
Purchase of computer and equipment		(11,155)
Promissory notes issued		(492,000)
Net cash used in investing activities	(25,000)	(1,279,257)
Cash flows from financing activities:
Proceeds from investor for issuance of SAFE notes	2,000,000	200,000
Proceeds from investor deposits	1,000,000
Proceeds from issuance of notes payable to related parties	1,000,000
Repayment of notes payable to related parties	(1,000,000)
Proceeds from stock issuance	90
Proceeds from exercise of warrants		1,561,655
Proceeds from issuance of convertible notes		2,100,000
Deferred transaction costs paid		(4,134,056)
Payment of SAFE note issuance cost to related parties	(435,000)
Proceeds from short-term loan		510,000
Repayment of short-term loan		(199,170)
Proceeds from of business combination and issuance of PIPE shares		11,639,088
Repayment of sponsor promissory notes		(1,562,834)
Repurchase of unvested shares		(6,003)
Net cash provided by financing activities	2,565,090	10,108,680
Net (decrease)/ increase in cash	957,661	315,262
Cash at the beginning of the period		1,271,824
Cash at the end of the period	957,661	1,587,086
Supplemental disclosure for cash flow information:
Interest paid	7,111	8,814
Supplemental disclosure of non-cash investing and financing activities:
Unpaid deferred transaction costs		3,470,991
Conversion of legacy SAFE notes		64
Conversion of legacy convertible notes		26
Sponsor earnout share liability		4,608,900
Issuance of common stock to Sponsor		400
Net liabilities assumed upon closing of business combination		14,638,315
Issuance of common stock to non-redeeming shareholders		13
Unpaid SAFE note issuance costs	31,302
Unpaid pre-acquisition capital project costs		$ 846,385